DIVITA CHARLES III

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DIVITA CHARLES III's trades of Teladoc Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
285.80
Quantity 63,641 -48.7%
Value US$4,196,609
Transaction date
Proposed sale
Price
102.87
Quantity 13,036
Value US$328,171
Transaction date
Sale
Price
146.90
Quantity 52,470 -14.7%
Value US$82,842
Transaction date
Proposed sale
Price
6.30
Quantity 18,327
Value US$115,484
Transaction date
Sale
Price
6.94
Quantity 18,074 -4.2%
Value US$125,470
Transaction date
Sale
Price
6.94
Quantity 18,074 -4.2%
Value US$125,470
Transaction date
Proposed sale
Price
6.94
Quantity 18,074
Value US$125,461
Transaction date
Sale
Price
7.63
Quantity 19,132 -4.7%
Value US$145,920
Transaction date
Proposed sale
Price
7.63
Quantity 19,132
Value US$145,920
Transaction date
Sale
Price
5.49
Quantity 27,731 -7.1%
Value US$152,243
Transaction date
Sale
Price
5.49
Quantity 27,731 -7.1%
Value US$152,243
Transaction date
Proposed sale
Price
5.49
Quantity 27,731
Value US$152,252
Transaction date
Sale
Price
5.12
Quantity 50,145 -13.3%
Value US$256,592
Transaction date
Proposed sale
Price
5.12
Quantity 50,145
Value US$256,577
Transaction date
Proposed sale
Price
7.63
Quantity 17,138
Value US$130,837
Transaction date
Sale
Price
7.63
Quantity 17,138 -7.9%
Value US$130,837
Transaction date
Proposed sale
Price
7.59
Quantity 16,787
Value US$127,435
Transaction date
Sale
Price
7.59
Quantity 16,787 -8.6%
Value US$127,435
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-11
S Sale
63,641 -48.7%
285.80
US$4,196,609 		63,641 -48.7% 285.80 US$4,196,609
2026-09-11 2026-09-11
PrS Proposed sale
13,036
102.87
US$328,171 		13,036 102.87 US$328,171
2026-09-03 2026-09-02
S Sale
52,470 -14.7%
146.90
US$82,842 		52,470 -14.7% 146.90 US$82,842
2026-09-02 2026-09-02
PrS Proposed sale
18,327
6.30
US$115,484 		18,327 6.30 US$115,484
2026-06-12 2026-06-11
S Sale
18,074 -4.2%
6.94
US$125,470 		18,074 -4.2% 6.94 US$125,470
2026-06-12 2026-06-11
S Sale
18,074 -4.2%
6.94
US$125,470 		18,074 -4.2% 6.94 US$125,470
2026-06-11 2026-06-11
PrS Proposed sale
18,074
6.94
US$125,461 		18,074 6.94 US$125,461
2026-06-03 2026-06-02
S Sale
19,132 -4.7%
7.63
US$145,920 		19,132 -4.7% 7.63 US$145,920
2026-06-02 2026-06-02
PrS Proposed sale
19,132
7.63
US$145,920 		19,132 7.63 US$145,920
2026-03-12 2026-03-11
S Sale
27,731 -7.1%
5.49
US$152,243 		27,731 -7.1% 5.49 US$152,243
2026-03-12 2026-03-11
S Sale
27,731 -7.1%
5.49
US$152,243 		27,731 -7.1% 5.49 US$152,243
2026-03-11 2026-03-11
PrS Proposed sale
27,731
5.49
US$152,252 		27,731 5.49 US$152,252
2026-03-03 2026-03-02
S Sale
50,145 -13.3%
5.12
US$256,592 		50,145 -13.3% 5.12 US$256,592
2026-03-02 2026-03-02
PrS Proposed sale
50,145
5.12
US$256,577 		50,145 5.12 US$256,577
2025-12-11 2025-12-11
PrS Proposed sale
17,138
7.63
US$130,837 		17,138 7.63 US$130,837
2025-12-11 2025-12-11
S Sale
17,138 -7.9%
7.63
US$130,837 		17,138 -7.9% 7.63 US$130,837
2025-09-11 2025-09-11
PrS Proposed sale
16,787
7.59
US$127,435 		16,787 7.59 US$127,435
2025-09-11 2025-09-11
S Sale
16,787 -8.6%
7.59
US$127,435 		16,787 -8.6% 7.59 US$127,435